Search alternatives:
larger decrease » marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
larger decrease » marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
741
-
742
-
743
-
744
-
745
-
746
-
747
-
748
Characteristics of HACE respondents by year.
Published 2025“…</p><p>Results</p><p>Overall patient satisfaction with general practice declined significantly over the 10 years, with mean positive scores dropping from 90.1% in 2011/12 to 70.5% in 2021/22. …”
-
749
-
750
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
751
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
752
-
753
-
754
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
755
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
756
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
757
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
758
-
759
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
760